Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center

Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center

Abstract Background Splenic marginal zone lymphoma (SMZL) is a rare lymphoid B-cell malignant neoplasm with primary involvement of the spleen. It is a chronic disease, of indolent behavior and prolonged survival. However, 25% of cases have higher biological aggressiveness, propensity for histologica...

Full description

Bibliographic Details
Main Authors: Luís Alberto de Pádua Covas Lage, Felipe Faganelli Caboclo dos Santos, Débora Levy, Frederico Rafael Moreira, Samuel Campanelli Freitas Couto, Hebert Fabrício Culler, Renata de Oliveira Costa, Vanderson Rocha, Juliana Pereira
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cancer
Subjects:
Splenic marginal zone lymphoma
Prognostic factors
Splenectomy
Rituximab
Poor-resource settings
Online Access:http://link.springer.com/article/10.1186/s12885-020-07204-6

Internet

http://link.springer.com/article/10.1186/s12885-020-07204-6

Similar Items